We are live on ! Find out more
ASPN icon

Aspen Aerogels

41 hedge funds and large institutions have $196M invested in Aspen Aerogels in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 5

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

41% more funds holding

Funds holding: 2941 (+12)

0.39% more ownership

Funds ownership: 84.27%84.66% (+0.39%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

8% less capital invested

Capital invested by funds: $214M → $196M (-$17.9M)

Holders
41
Holders Change
+12
Holders Change %
+41.38%
% of All Funds
1.19%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
18
Increased
13
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ASPN Hedge Fund Activity: Q3 2014 in Review

41 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q3 2014, worth a combined $196M — down 8.3% from $214M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ASPN positions and 5 closed out — a net gain of 13 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $5.81M. The largest seller was Barclays, exiting entirely with an estimated $11.9M sold.

  • 41 institutional investors held Aspen Aerogels (ASPN) as of Q3 2014, up from 29 in Q2 2014.
  • Funds reported $196M of Aspen Aerogels stock for Q3 2014, down 8.3% quarter-over-quarter.
  • 18 funds opened new Aspen Aerogels positions in Q3 2014 and 5 closed out, a net change of +13 holders.
  • The largest Aspen Aerogels buyer in Q3 2014 was Gilder Gagnon Howe & Co, an estimated $5.81M added.
  • The largest Aspen Aerogels seller in Q3 2014 was Barclays, an estimated $11.9M sold.

Based on aggregated 13F filings for Q3 2014.